Literature DB >> 22361342

Mapping the growth hormone--Stat5b--IGF-I transcriptional circuit.

Peter Rotwein1.   

Abstract

Growth hormone (GH) and insulin-like growth factor-I (IGF-I) exert powerful influences on somatic growth, metabolism, and tissue repair, and have been implicated in aging and carcinogenesis. Since the formulation of the somatomedin hypothesis over 50 years ago, GH and IGF-I have been linked intimately to one another. Recent studies have established that GH potently stimulates IGF-I gene transcription, and through this mechanism controls production of IGF-I. A key mediator of the GH-IGF-I biosynthetic pathway is the latent transcription factor Stat5b. This review summarizes the potentially complex mechanistic relationship between GH action, Stat5b, and IGF-I gene activation, and suggests that Stat5b may have a broad role in mediating IGF-I gene regulation in response to diverse physiological inputs. Copyright Â
© 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22361342      PMCID: PMC3313013          DOI: 10.1016/j.tem.2012.01.001

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  81 in total

1.  BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.

Authors:  C C Chang; B H Ye; R S Chaganti; R Dalla-Favera
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

Review 2.  Nuclear receptors: one big family.

Authors:  Iain J McEwan
Journal:  Methods Mol Biol       Date:  2009

3.  Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.

Authors:  Nathaniel D Heintzman; Rhona K Stuart; Gary Hon; Yutao Fu; Christina W Ching; R David Hawkins; Leah O Barrera; Sara Van Calcar; Chunxu Qu; Keith A Ching; Wei Wang; Zhiping Weng; Roland D Green; Gregory E Crawford; Bing Ren
Journal:  Nat Genet       Date:  2007-02-04       Impact factor: 38.330

Review 4.  Estrogen receptors: therapies targeted to receptor subtypes.

Authors:  S Nilsson; J-Å Gustafsson
Journal:  Clin Pharmacol Ther       Date:  2010-12-01       Impact factor: 6.875

5.  Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression.

Authors:  Ying Wang; Honglin Jiang
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

Review 6.  Disorders of bone remodeling.

Authors:  Xu Feng; Jay M McDonald
Journal:  Annu Rev Pathol       Date:  2011       Impact factor: 23.472

Review 7.  Growth hormone and adipose tissue: beyond the adipocyte.

Authors:  Darlene E Berryman; Edward O List; Lucila Sackmann-Sala; Ellen Lubbers; Rachel Munn; John J Kopchick
Journal:  Growth Horm IGF Res       Date:  2011-04-05       Impact factor: 2.372

8.  Dynamic in vivo binding of STAT5 to growth hormone-regulated genes in intact rat liver. Sex-specific binding at low- but not high-affinity STAT5 sites.

Authors:  Ekaterina V Laz; Aarathi Sugathan; David J Waxman
Journal:  Mol Endocrinol       Date:  2009-05-07

Review 9.  Glucocorticoid receptor physiology.

Authors:  Marjet D Heitzer; Irene M Wolf; Edwin R Sanchez; Selma F Witchel; Donald B DeFranco
Journal:  Rev Endocr Metab Disord       Date:  2007-12       Impact factor: 6.514

Review 10.  Hormone families: pancreatic hormones and homologous growth factors.

Authors:  T L Blundell; R E Humbel
Journal:  Nature       Date:  1980-10-30       Impact factor: 49.962

View more
  45 in total

1.  Editorial: is it time for an evolutionarily based human endocrinology?

Authors:  Peter S Rotwein
Journal:  Mol Endocrinol       Date:  2015-04

2.  Defining human insulin-like growth factor I gene regulation.

Authors:  Aditi Mukherjee; Damir Alzhanov; Peter Rotwein
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-07-12       Impact factor: 4.310

Review 3.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

4.  Induction of IL-6 by Cytotoxic Chemotherapy Is Associated With Loss of Lean Body and Fat Mass in Tumor-free Female Mice.

Authors:  Collin R Elsea; Janet A Kneiss; Lisa J Wood
Journal:  Biol Res Nurs       Date:  2014-11-18       Impact factor: 2.522

5.  Severe growth deficiency is associated with STAT5b mutations that disrupt protein folding and activity.

Authors:  Benjamin Varco-Merth; Eva Feigerlová; Ujwal Shinde; Ron G Rosenfeld; Vivian Hwa; Peter Rotwein
Journal:  Mol Endocrinol       Date:  2012-11-16

6.  Growth hormone receptor signaling is dispensable for HSC function and aging.

Authors:  Morag H Stewart; Paula Gutierrez-Martinez; Isabel Beerman; Brian Garrison; Emily J Gallagher; Derek LeRoith; Derrick J Rossi
Journal:  Blood       Date:  2014-10-01       Impact factor: 22.113

7.  RNAi-mediated gene silencing of ST6GalNAc I suppresses the metastatic potential in gastric cancer cells.

Authors:  Fumito Tamura; Yasushi Sato; Masahiro Hirakawa; Makoto Yoshida; Michihiro Ono; Takahiro Osuga; Yutaka Okagawa; Naoki Uemura; Yohei Arihara; Kazuyuki Murase; Yutaka Kawano; Satoshi Iyama; Kohichi Takada; Tsuyoshi Hayashi; Tsutomu Sato; Koji Miyanishi; Masayoshi Kobune; Rishu Takimoto; Junji Kato
Journal:  Gastric Cancer       Date:  2014-12-23       Impact factor: 7.370

8.  Variation in the Insulin-Like Growth Factor 1 Gene in Primates.

Authors:  Peter Rotwein
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

9.  Identifying growth hormone-regulated enhancers in the Igf1 locus.

Authors:  Damir Alzhanov; Aditi Mukherjee; Peter Rotwein
Journal:  Physiol Genomics       Date:  2015-09-01       Impact factor: 3.107

10.  Hepatic-specific accessibility of Igf1 gene enhancers is independent of growth hormone signaling.

Authors:  Mahalakshmi Santhanam; Dennis J Chia
Journal:  Mol Endocrinol       Date:  2013-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.